top of page

Alice Finkelstein

Edward Njoo

During her time in the Njoo group at ASDRP, Alice was a part of the chemical neuroscience subgroup where she helped synthesize and test the activity of analogs of rivastigmine, a drug used to treat neurodegenerative diseases. This work was published in the Journal of Emerging Investigators ( Alice was also in the NNRTI subgroup, where she worked on optimizing the Buchwald-Hartwig cross-coupling reaction to synthesize and screen a library of N,N-diaryl pyrimidine-2,4-diamines with the goal of terminating viral HIV reproduction.

Stanford University


Alice Finkelstein
bottom of page